|
|
 |
|
Viewing report
|
|
|
|
European Market for Interventional Oncology Technology
Frost & Sullivan, Dec 2010, Pages: 134
This research service provides a qualitative and quantitative analysis for interventional oncology technologies market in Europe. The rise in aging population and increased occurrence of cancer - liver , lung, kidney, breast and prostrate across the globe has increased the demand for the treatment of cancer using minimally invasive technologies. These technologies reduce the stay in hospital and are user-friendly. Though the traditional method for treatment of cancer are still preferred by oncologist, the right kind of promotional strategies along with increased reimbursement policies could boost the market for interventional oncology technology.
This research service titled European Market for Interventional Oncology Technology offers a comprehensive examination of the market including key drivers restraints, challenges and strategic recommendations. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: radio frequency ablation (RFA), microwave ablation (MWA), hi frequency focused ultrasound (HIFU) and cryoablation.
Market Overview:
Expanded Awareness and Availability of Patient-friendly Treatment Procedures to Boost Adoption of Interventional Oncology Technology
The interventional oncology technology market in Europe is in its growth stage. Increased awareness about cancer and the different kinds of interventional oncology technologies available to treat this disease are spurring market prospects. The focus is on easy-to-use, patient-friendly and minimally invasive technology devices. “The most important driver in the market is the requirement of easy-to-use and patient-friendly minimally invasive or non–invasive devices that support enhanced cancer therapy management,” notes the analyst of this research. “The increasing demand for patient-friendly, easy-to-operate and well designed equipment at affordable prices will boost the sales of technologically advanced products.”
The rapid greying of western Europe has been accompanied by the increased occurrence of diseases like cancer. This has further underlined the need for methods that can detect and treat cancer at the earliest, thus saving patients’ lives. “This has motivated the demand for patient-friendly minimally invasive technologies to cure cancer,” says the analyst. “There is an urgent demand for novel, low-cost technologies that reduce the duration of hospitalisation, while offering patients rapid and robust treatment for cancer.”
Low Reimbursement Levels Pose a Challenge:
The low reimbursement rate for interventional oncology technology as compared to the traditional form of treating cancer – surgery – has led to a decline in the number of patients opting for these advanced treatment methods. The traditional method of using surgery as a mode of treatment for cancer is available to patients at a much lower rate and is reimbursed across Europe. At present, the medical community also considers it as the most trusted method. On the other hand, using interventional oncology technology makes the treatment extremely expensive, thus hindering their uptake.
“Collaboration with established local companies would help the manufacturers of niche technologies to provide effective services, while maintaining profit margins,” advises the analyst. “To succeed, manufacturers must provide innovative, accurate and reliable patient friendly devices.”
Market Sectors:
Expert analysts thoroughly examine the following market sectors in this research:
- Radio frequency ablation (RFA)
- Microwave ablation (MWA)
- Hi frequency focused ultrasound (HIFU)
- Cryoablation
By Geographic Region:
- Benelux
- France
- Germany
- Italy
- Scandinavia
- Spain
- The United Kingdom
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
